These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12609590)

  • 1. Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
    Wesson KM; Lerner DS; Silverberg NB; Weinberg JM
    Clin Dermatol; 2003; 21(1):64-70. PubMed ID: 12609590
    [No Abstract]   [Full Text] [Related]  

  • 2. Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
    Wesson KM; Lerner DS; Silverberg NB; Weinberg JM
    Dis Mon; 2004 Jul; 50(7):395-406. PubMed ID: 15280870
    [No Abstract]   [Full Text] [Related]  

  • 3. Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
    Schweiger ES; Scheinfeld NS; Tischler HR; Weinberg JM
    J Drugs Dermatol; 2003 Aug; 2(4):378-83. PubMed ID: 12884459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two new treatment options for infections due to drug-resistant gram-positive cocci.
    Rehm SJ
    Cleve Clin J Med; 2002 May; 69(5):397-401, 405-13. PubMed ID: 12022383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
    Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
    Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antibacterial agents for skin and skin structure infections.
    Schweiger ES; Weinberg JM
    J Am Acad Dermatol; 2004 Mar; 50(3):331-40; quiz 341-2. PubMed ID: 14988672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
    Tamma PD; Hsu AJ
    Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?
    Livermore DM
    J Antimicrob Chemother; 2000 Sep; 46(3):347-50. PubMed ID: 10980159
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
    J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
    Batts DH; Lavin BS; Eliopoulos GM
    Curr Clin Top Infect Dis; 2001; 21():227-51. PubMed ID: 11572153
    [No Abstract]   [Full Text] [Related]  

  • 13. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
    Manfredi R
    Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Listeria monocytogenes meningitis and multiple brain abscesses in an immunocompetent host. Favorable response to combination linezolid-meropenem treatment.
    Manfredi R; Sabbatani S; Marinacci G; Salizzoni E; Chiodo F
    J Chemother; 2006 Jun; 18(3):331-3. PubMed ID: 17129848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of SSTI and role of tigecycline].
    Concia E
    Infez Med; 2009 Sep; 17 Suppl 4():64-76. PubMed ID: 20428022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New anti-Gram+antibiotics: which role in infective endocarditis?].
    Makinson A; Le Moing V
    Ann Cardiol Angeiol (Paris); 2008 Apr; 57(2):88-92. PubMed ID: 18395180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
    Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acidosis and linezolid-induced pancytopaenia.
    Carbajo T; Fenollosa M; Pons R; Calvo C
    Nefrologia; 2011; 31(1):107-8. PubMed ID: 21270922
    [No Abstract]   [Full Text] [Related]  

  • 20. [Linezolid-induced anemia].
    Acha V; Zaragüeta M; Martínez Y; Cobo F
    Enferm Infecc Microbiol Clin; 2003; 21(6):321-2. PubMed ID: 12809592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.